Methyl 2-(3-(3-chlorophenyl)ureido)thiophene-3-carboxylate

Catalog No. :
ACYRZZ405
CAS No. :
338777-31-4
Molecular Formula :
C13H11ClN2O3S
Molecular Weight :
310.76

IUPAC Name:methyl 2-(3-(3-chlorophenyl)ureido)thiophene-3-carboxylate

Methyl 2-(3-(3-chlorophenyl)ureido)thiophene-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-(3-(3-chlorophenyl)ureido)thiophene-3-carboxylate
IUPAC Namemethyl 2-(3-(3-chlorophenyl)ureido)thiophene-3-carboxylate
MDL No.MFCD01316165
Molecular FormulaC13H11ClN2O3S
Molecular Weight310.76
SMILESO=C(C1=C(NC(NC2=CC=CC(Cl)=C2)=O)SC=C1)OC
InChI KeyLECOHRWYWBZVJB-UHFFFAOYSA-N
SynonymMETHYL 2-([(3-CHLOROANILINO)CARBONYL]AMINO)-3-THIOPHENECARBOXYLATE;methyl 2-{[(3-chlorophenyl)carbamoyl]amino}thiophene-3-carboxylate;3-Thiophenecarboxylic acid, 2-[[[(3-chlorophenyl)amino]carbonyl]amino]-, methyl ester
CAS No.338777-31-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACYRZZ405 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNRXD892 route compound structure diagram
    ACNRXD8924651-81-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYRZZ405 route product structure diagram
    ACYRZZ405338777-31-4
Inquiry

2. ACYRZZ405 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYRZZ405 route product structure diagram
    ACYRZZ405338777-31-4
Inquiry

Comments (0)